Cargando…
Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists
In this review, we sought to address 2 important issues in the diagnosis of endometrial carcinoma: how to grade endometrial endometrioid carcinomas and how to incorporate the 4 genomic subcategories of endometrial carcinoma, as identified through The Cancer Genome Atlas, into clinical practice. The...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295928/ https://www.ncbi.nlm.nih.gov/pubmed/30550484 http://dx.doi.org/10.1097/PGP.0000000000000518 |
_version_ | 1783380943228108800 |
---|---|
author | Soslow, Robert A. Tornos, Carmen Park, Kay J. Malpica, Anais Matias-Guiu, Xavier Oliva, Esther Parkash, Vinita Carlson, Joseph McCluggage, W. Glenn Gilks, C. Blake |
author_facet | Soslow, Robert A. Tornos, Carmen Park, Kay J. Malpica, Anais Matias-Guiu, Xavier Oliva, Esther Parkash, Vinita Carlson, Joseph McCluggage, W. Glenn Gilks, C. Blake |
author_sort | Soslow, Robert A. |
collection | PubMed |
description | In this review, we sought to address 2 important issues in the diagnosis of endometrial carcinoma: how to grade endometrial endometrioid carcinomas and how to incorporate the 4 genomic subcategories of endometrial carcinoma, as identified through The Cancer Genome Atlas, into clinical practice. The current International Federation of Gynecology and Obstetrics grading scheme provides prognostic information that can be used to guide the extent of surgery and use of adjuvant chemotherapy or radiation therapy. We recommend moving toward a binary scheme to grade endometrial endometrioid carcinomas by considering International Federation of Gynecology and Obstetrics defined grades 1 and 2 tumors as “low grade” and grade 3 tumors as “high grade.” The current evidence base does not support the use of a 3-tiered grading system, although this is considered standard by International Federation of Gynecology and Obstetrics, the American College of Obstetricians and Gynecologists, and the College of American Pathologists. As for the 4 genomic subtypes of endometrial carcinoma (copy number low/p53 wild-type, copy number high/p53 abnormal, polymerase E mutant, and mismatch repair deficient), which only recently have been identified, there is accumulating evidence showing these categories can be reproducibly diagnosed and accurately assessed based on biopsy/curettage specimens as well as hysterectomy specimens. Furthermore, this subclassification system can be adapted for current clinical practice and is of prognostic significance independent of conventional variables used for risk assessment in patients with endometrial carcinoma (eg, stage). It is too soon to recommend the routine use of genomic classification in this setting; however, with further evidence, this system may become the basis for the subclassification of all endometrial carcinomas, supplanting (partially or completely) histotype, and grade. These recommendations were developed from the International Society of Gynecological Pathologists Endometrial Carcinoma project. |
format | Online Article Text |
id | pubmed-6295928 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-62959282018-12-26 Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists Soslow, Robert A. Tornos, Carmen Park, Kay J. Malpica, Anais Matias-Guiu, Xavier Oliva, Esther Parkash, Vinita Carlson, Joseph McCluggage, W. Glenn Gilks, C. Blake Int J Gynecol Pathol Articles In this review, we sought to address 2 important issues in the diagnosis of endometrial carcinoma: how to grade endometrial endometrioid carcinomas and how to incorporate the 4 genomic subcategories of endometrial carcinoma, as identified through The Cancer Genome Atlas, into clinical practice. The current International Federation of Gynecology and Obstetrics grading scheme provides prognostic information that can be used to guide the extent of surgery and use of adjuvant chemotherapy or radiation therapy. We recommend moving toward a binary scheme to grade endometrial endometrioid carcinomas by considering International Federation of Gynecology and Obstetrics defined grades 1 and 2 tumors as “low grade” and grade 3 tumors as “high grade.” The current evidence base does not support the use of a 3-tiered grading system, although this is considered standard by International Federation of Gynecology and Obstetrics, the American College of Obstetricians and Gynecologists, and the College of American Pathologists. As for the 4 genomic subtypes of endometrial carcinoma (copy number low/p53 wild-type, copy number high/p53 abnormal, polymerase E mutant, and mismatch repair deficient), which only recently have been identified, there is accumulating evidence showing these categories can be reproducibly diagnosed and accurately assessed based on biopsy/curettage specimens as well as hysterectomy specimens. Furthermore, this subclassification system can be adapted for current clinical practice and is of prognostic significance independent of conventional variables used for risk assessment in patients with endometrial carcinoma (eg, stage). It is too soon to recommend the routine use of genomic classification in this setting; however, with further evidence, this system may become the basis for the subclassification of all endometrial carcinomas, supplanting (partially or completely) histotype, and grade. These recommendations were developed from the International Society of Gynecological Pathologists Endometrial Carcinoma project. Lippincott Williams & Wilkins 2019-01 2018-12-14 /pmc/articles/PMC6295928/ /pubmed/30550484 http://dx.doi.org/10.1097/PGP.0000000000000518 Text en Copyright © 2018 International Society of Gynecological Pathologists. Published by Wolters Kluwer Health, Inc. on behalf of the International Society of Gynecological Pathologists. This is an open access article distributed under the Creative Commons Attribution License 4.0 (http://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Articles Soslow, Robert A. Tornos, Carmen Park, Kay J. Malpica, Anais Matias-Guiu, Xavier Oliva, Esther Parkash, Vinita Carlson, Joseph McCluggage, W. Glenn Gilks, C. Blake Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists |
title | Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists |
title_full | Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists |
title_fullStr | Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists |
title_full_unstemmed | Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists |
title_short | Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists |
title_sort | endometrial carcinoma diagnosis: use of figo grading and genomic subcategories in clinical practice: recommendations of the international society of gynecological pathologists |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295928/ https://www.ncbi.nlm.nih.gov/pubmed/30550484 http://dx.doi.org/10.1097/PGP.0000000000000518 |
work_keys_str_mv | AT soslowroberta endometrialcarcinomadiagnosisuseoffigogradingandgenomicsubcategoriesinclinicalpracticerecommendationsoftheinternationalsocietyofgynecologicalpathologists AT tornoscarmen endometrialcarcinomadiagnosisuseoffigogradingandgenomicsubcategoriesinclinicalpracticerecommendationsoftheinternationalsocietyofgynecologicalpathologists AT parkkayj endometrialcarcinomadiagnosisuseoffigogradingandgenomicsubcategoriesinclinicalpracticerecommendationsoftheinternationalsocietyofgynecologicalpathologists AT malpicaanais endometrialcarcinomadiagnosisuseoffigogradingandgenomicsubcategoriesinclinicalpracticerecommendationsoftheinternationalsocietyofgynecologicalpathologists AT matiasguiuxavier endometrialcarcinomadiagnosisuseoffigogradingandgenomicsubcategoriesinclinicalpracticerecommendationsoftheinternationalsocietyofgynecologicalpathologists AT olivaesther endometrialcarcinomadiagnosisuseoffigogradingandgenomicsubcategoriesinclinicalpracticerecommendationsoftheinternationalsocietyofgynecologicalpathologists AT parkashvinita endometrialcarcinomadiagnosisuseoffigogradingandgenomicsubcategoriesinclinicalpracticerecommendationsoftheinternationalsocietyofgynecologicalpathologists AT carlsonjoseph endometrialcarcinomadiagnosisuseoffigogradingandgenomicsubcategoriesinclinicalpracticerecommendationsoftheinternationalsocietyofgynecologicalpathologists AT mccluggagewglenn endometrialcarcinomadiagnosisuseoffigogradingandgenomicsubcategoriesinclinicalpracticerecommendationsoftheinternationalsocietyofgynecologicalpathologists AT gilkscblake endometrialcarcinomadiagnosisuseoffigogradingandgenomicsubcategoriesinclinicalpracticerecommendationsoftheinternationalsocietyofgynecologicalpathologists |